Company Description
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide.
The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry.
It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions.
In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com.
Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
| Country | United States |
| Founded | 1989 |
| IPO Date | Aug 8, 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3,600 |
| CEO | Catherine Szyman |
Contact Details
Address: 52 Discovery Irvine, California 92618 United States | |
| Phone | 949 297 7000 |
| Website | masimo.com |
Stock Details
| Ticker Symbol | MASI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000937556 |
| CUSIP Number | 574795100 |
| ISIN Number | US5747951003 |
| Employer ID | 33-0368882 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Catherine M. Szyman | Chief Executive Officer and Director |
| Micah Young CPA | Chief Financial Officer |
| Bilal Muhsin | Chief Operating Officer |
| Blair Tripodi | Chief Operating Officer of Consumer Division |
| Paul Hataishi | Senior Vice President and Chief Accounting Officer |
| Yongsam Lee | Executive Vice President and Chief Information Officer |
| Dr. Steven J. Barker | Chairman of Scientific Advisory Board and Chief Science Officer |
| Eli Kammerman | Vice President of Business Development and Investor Relations |
| Tim Benner | Chief Marketing and Strategy Officer |
| Elisabeth A. Hellmann | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 3, 2025 | 4 | Statement of changes in beneficial ownership of securities |
| Jun 26, 2025 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 12, 2025 | 8-K | Current Report |
| May 27, 2025 | SD | Form - SD |
| May 27, 2025 | 8-K | Current Report |
| May 13, 2025 | 144 | Filing |
| May 12, 2025 | 144 | Filing |
| May 12, 2025 | 144 | Filing |
| May 7, 2025 | 8-K/A | [Amend] Current report |
| May 6, 2025 | 10-Q | Quarterly Report |